#	Pagina
attuale pagina	/open-h2020/projects/226542/index.html
-1	/open-h2020/projects/218771/index.html
-2	/open-h2020/projects/219700/index.html
-3	/open-h2020/per-topic/plast2bcleaned/list/index.html
-4	/open-h2020/per-topic/germs/list/index.html
-5	/open-h2020/per-topic/apts/list/index.html
-6	/open-h2020/per-topic/msnps/list/index.html
-7	/open-h2020/per-topic/genoidentical/list/index.html
-8	/open-h2020/per-topic/sumos/list/index.html
-9	/open-h2020/per-topic/misinformation/list/index.html

Opendata, web and dolomites

REMEDIA SIGNED

Impact of exposome on the course of lung diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

REMEDIA project word cloud

Explore the words cloud of the REMEDIA project. It provides you a very rough idea of what is the project "REMEDIA" about.

global identification cf tool roots unified model sensor 2020 recommendations chronic simulate morbidity origin modifiable econometric risk data remedia supplemented risks deciphering biomarker performance machine gathering device flexible phenotype database individual outside life cohorts picture learning prevents health exposomes causal therapeutic obstructive external supervised create communicable toolkits play inference breakthrough combining population debilitating registries mainly sc1 prevention additional good reducing disease action 2018 opposite pulmonary efficacy contribution parallel fibrosis share variability extend pan predict guidelines phenotypic diseases environmental copd components bhc unknown toolbox criteria clear human chamber cystic models effectiveness curable constitute simulation atmospheric preventive strategies versatile exposome network mortality

Project "REMEDIA" data sheet

The following table provides information about the project.

Coordinator	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Organization address address: RUE DE TOLBIAC 101 city: PARIS postcode: 75654 website: www.inserm.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	France [FR]
Total cost	11˙134˙616 €
EC max contribution	11˙134˙616 € (100%)
Programme	1. H2020-EU.3.1.2. (Preventing disease)
Code Call	H2020-SC1-2019-Single-Stage-RTD
Funding Scheme	RIA
Starting year	2020
Duration (year-month-day)	from 2020-01-01 to 2024-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Organization address address: RUE DE TOLBIAC 101 city: PARIS postcode: 75654 website: www.inserm.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	coordinator	2˙332˙877.00
2	UNIVERSITE DE PARIS UNIVERSITE DE PARIS Organization address address: 85 BD SAINT GERMAIN city: PARIS postcode: 75006 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	1˙672˙881.00
3	FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. Organization address address: HANSASTRASSE 27C city: MUNCHEN postcode: 80686 website: www.fraunhofer.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUNCHEN)	participant	1˙611˙674.00
4	CAMBRIDGE EPIGENETIX LIMITED CAMBRIDGE EPIGENETIX LIMITED Organization address address: CHESTERFORD RESEARCH PARK TRINITY BUILDING B400 city: SAFFRON WALDEN postcode: CB10 1XL website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (SAFFRON WALDEN)	participant	1˙037˙694.00
5	DATA MINING INTERNATIONAL SA DATA MINING INTERNATIONAL SA Organization address address: ROUTE DE PRE-BOIS 29 city: GENEVE postcode: 1215 website: www.datamining-international.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (GENEVE)	participant	777˙500.00
6	LIPOTYPE LIPOTYPE Organization address address: TATZBERG 47 city: DRESDEN postcode: 1307 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (DRESDEN)	participant	731˙250.00
7	CENTRE HOSPITALIER INTERCOMMUNAL DE CRETEIL CENTRE HOSPITALIER INTERCOMMUNAL DE CRETEIL Organization address address: AVENUE DE VERDUN 40 city: CRETEIL postcode: 94010 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (CRETEIL)	participant	628˙315.00
8	KATHOLIEKE UNIVERSITEIT LEUVEN KATHOLIEKE UNIVERSITEIT LEUVEN Organization address address: OUDE MARKT 13 city: LEUVEN postcode: 3000 website: www.kuleuven.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (LEUVEN)	participant	625˙750.00
9	IDRYMA TECHNOLOGIAS KAI EREVNAS IDRYMA TECHNOLOGIAS KAI EREVNAS Organization address address: N PLASTIRA STR 100 city: IRAKLEIO postcode: 70013 website: www.forth.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (IRAKLEIO)	participant	462˙500.00
10	INSERM TRANSFERT SA INSERM TRANSFERT SA Organization address address: RUE WATT 7 city: PARIS postcode: 75013 website: www.inserm-transfert.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	442˙500.00
11	UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET Organization address address: HANSINE HANSENS VEG 14 city: TROMSO postcode: 9019 website: http://uit.no/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (TROMSO)	participant	345˙617.00
12	KRAEFTENS BEKAEMPELSE KRAEFTENS BEKAEMPELSE Organization address address: STRANDBOULEVARDEN 49 city: KOEBENHAVN postcode: 2100 website: http://www.cancer.dk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOEBENHAVN)	participant	258˙556.00
13	LAURENT NIDDAM EUROPAI KOZOSSEGI JOGASZ IRODA LAURENT NIDDAM EUROPAI KOZOSSEGI JOGASZ IRODA Organization address address: CSARNOK TER 3 4 IV 8 city: BUDAPEST postcode: 1093 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	207˙500.00
14	UNIVERSITE PARIS DIDEROT - PARIS 7 UNIVERSITE PARIS DIDEROT - PARIS 7 Organization address address: RUE THOMAS MANN 5 city: PARIS postcode: 75205 website: www.univ-paris-diderot.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	0.00

Map

Project objective

Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are two very debilitating non-communicable diseases that are of particular interest to consider in parallel in a human exposome study. Their roots are opposite: COPD is currently considered to be mainly related to the external exposome, while factors outside of the exposome play a major role in CF. However, COPD and CF share common characteristics such as high phenotypic variability of unknown origin, which prevents good therapeutic efficacy. It is therefore clear that the overall picture must be supplemented by taking into account additional components of the exposome than those currently considered in COPD and CF. Thus, the overall objective of the REMEDIA project is to extend the understanding of the contribution of the exposome, taken as a complex set of different components, to COPD and CF diseases. We will exploit data from existing cohorts and population registries in order to create a unified global database gathering phenotype and exposome information; we will develop a flexible individual sensor device combining environmental and biomarker toolkits; and use a versatile atmospheric simulation chamber to simulate the health effects of complex exposomes. We will use machine learning supervised analyses and causal inference models to identify relevant risk factors; and econometric and cost-effectiveness models to assess the costs, performance and cost-effectiveness of a selection of prevention strategies. The results will be used to develop guidelines to better predict disease risks and constitute the elements of the REMEDIA toolbox (global unified database, sensor device, versatile atmospheric simulation chamber, machine learning supervised analyses, causal inference model, Pan-European multi-criteria risk assessment tool, econometric models, cost-effectiveness models, new guidelines and recommendations). Deciphering the impact of environmental components throughout life on the phenotypic variability of COPD and CF could represent a major breakthrough in reducing morbidity and mortality associated with these two non-curable diseases and would lead to the identification of modifiable risk factors on which preventive action could be implemented. REMEDIA will be part of the European Human Exposome Network established between the 9 projects funded within the Human Exposome programme call H2020-SC1-BHC-2018-2020.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REMEDIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REMEDIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.2.)

EMPOWER (2020)

European platforM to PromOte Wellbeing and HEalth in the woRkplace

Read More

RISCC (2020)

RISK-BASED SCREENING FOR CERVICAL CANCER

Read More

HEAP (2020)

Human Exposome Assessment Platform

Read More